Lupus & antiphospholipid syndrome
Development and evaluation of frailty index for patients with systemic lupus erythematosus in China
Authors' conclusion
The frailty index scale developed in this study is a valid and reliable tool for assessing frailty in SLE patients in China, with potential utility in clinical and research settings.
Study context
- Population
- Patients with systemic lupus erythematosus (SLE) in Chinapilot: 50 SLE patients
- Outcome
- Validity and reliability of the SLE frailty index scale
Methodological detailstwo-round Delphi expert consultation, pre-survey and formal survey
- Two-round Delphi expert consultation
- Pre-survey and formal survey
Performance
As reported in the abstract
- Final scale items
- 14
- Cronbach's α coefficient
- 0.809
- Split-half reliability
- 0.745
- KMO
- 0.820
- Bartlett's test value
- 2915.855 (p < 0.001)
- Overall correlation coefficient
- 0.832 (p < 0.001)
- Item-dimension correlation coefficient, except for a few items
- >0.4
- Optimal cutoff, pre-frailty stage
- 28.5
- Optimal cutoff, frailty stage
- 40.5
Further findings
Item reduction
- Initial item pool: 3 dimensions, items
- 32
- After two Delphi rounds: 3 dimensions, items
- 21
Original publication
Development and evaluation of frailty index for patients with systemic lupus erythematosus in China. Lupus. Published 4 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →